Listed

Enliven Therapeutics, Inc.

ELVNNasdaqCIK 1672619HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$37.2m, Q2 FY2026
Net income−$32.5m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m19.6Research and development, Q3 FY2023, three months to 2023-09-30$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure17.9Research and development, Q4 FY2023, three months to 2023-12-31$17.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figure20.0Research and development, Q1 FY2024, three months to 2024-03-31$20.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure18.8Research and development, Q2 FY2024, three months to 2024-06-30$18.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure21.3Research and development, Q3 FY2024, three months to 2024-09-30$21.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure20.7Research and development, Q4 FY2024, three months to 2024-12-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure24.9Research and development, Q1 FY2025, three months to 2025-03-31$24.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure21.5Research and development, Q2 FY2025, three months to 2025-06-30$21.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure18.2Research and development, Q3 FY2025, three months to 2025-09-30$18.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure21.2Research and development, Q4 FY2025, three months to 2025-12-31$21.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure20.7Research and development, Q1 FY2026, three months to 2026-03-31$20.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure29.0Research and development, Q2 FY2026, three months to 2026-06-30$29.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Operating income$m(24.2)Operating income, Q3 FY2023, three months to 2023-09-30−$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure(22.7)Operating income, Q4 FY2023, three months to 2023-12-31−$22.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figure(26.0)Operating income, Q1 FY2024, three months to 2024-03-31−$26.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure(24.6)Operating income, Q2 FY2024, three months to 2024-06-30−$24.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure(27.1)Operating income, Q3 FY2024, three months to 2024-09-30−$27.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(26.9)Operating income, Q4 FY2024, three months to 2024-12-31−$26.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(31.7)Operating income, Q1 FY2025, three months to 2025-03-31−$31.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(28.6)Operating income, Q2 FY2025, three months to 2025-06-30−$28.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(25.1)Operating income, Q3 FY2025, three months to 2025-09-30−$25.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(34.3)Operating income, Q4 FY2025, three months to 2025-12-31−$34.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(27.8)Operating income, Q1 FY2026, three months to 2026-03-31−$27.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(37.2)Operating income, Q2 FY2026, three months to 2026-06-30−$37.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.2Income tax, Q2 FY2024, three months to 2024-06-30$232.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$m(20.8)Net income, Q3 FY2023, three months to 2023-09-30−$20.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure(19.4)Net income, Q4 FY2023, three months to 2023-12-31−$19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figure(22.7)Net income, Q1 FY2024, three months to 2024-03-31−$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(20.0)Net income, Q2 FY2024, three months to 2024-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(23.2)Net income, Q3 FY2024, three months to 2024-09-30−$23.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(23.2)Net income, Q4 FY2024, three months to 2024-12-31−$23.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(28.5)Net income, Q1 FY2025, three months to 2025-03-31−$28.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(25.3)Net income, Q2 FY2025, three months to 2025-06-30−$25.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(20.1)Net income, Q3 FY2025, three months to 2025-09-30−$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure(29.7)Net income, Q4 FY2025, three months to 2025-12-31−$29.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(23.6)Net income, Q1 FY2026, three months to 2026-03-31−$23.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(32.5)Net income, Q2 FY2026, three months to 2026-06-30−$32.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Diluted EPS$ per share(0.51)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figurenot reported(0.54)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure(0.41)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure(0.48)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figurenot reported(0.57)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(0.49)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(0.32)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figurenot reported(0.38)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(0.49)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Basic EPS$ per share(0.51)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figurenot reported(0.54)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure(0.41)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure(0.48)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.48 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figurenot reported(0.57)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(0.49)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure(0.32)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figurenot reported(0.38)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(0.49)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure

Balance sheet

Cash and equivalents$135.5m, Q2 FY2026
Shareholders' equity$895.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m73.8Cash and equivalents, Q3 FY2023, at 2023-09-30$73.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure100Cash and equivalents, FY2023, at 2023-12-31$100.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0000950170-25-038758.Report this figure149Cash and equivalents, Q1 FY2024, at 2024-03-31$149.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure96.9Cash and equivalents, Q2 FY2024, at 2024-06-30$96.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure101Cash and equivalents, Q3 FY2024, at 2024-09-30$100.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure124Cash and equivalents, FY2024, at 2024-12-31$124.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure102Cash and equivalents, Q1 FY2025, at 2025-03-31$101.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure119Cash and equivalents, Q2 FY2025, at 2025-06-30$119.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure102Cash and equivalents, Q3 FY2025, at 2025-09-30$101.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure98.9Cash and equivalents, FY2025, at 2025-12-31$98.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure132Cash and equivalents, Q1 FY2026, at 2026-03-31$132.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure136Cash and equivalents, Q2 FY2026, at 2026-06-30$135.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Current assets$m269Current assets, Q3 FY2023, at 2023-09-30$268.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062080.Report this figure266Current assets, FY2023, at 2023-12-31$266.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038758.Report this figure337Current assets, Q1 FY2024, at 2024-03-31$337.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059573.Report this figure318Current assets, Q2 FY2024, at 2024-06-30$318.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure297Current assets, Q3 FY2024, at 2024-09-30$297.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure318Current assets, FY2024, at 2024-12-31$318.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure294Current assets, Q1 FY2025, at 2025-03-31$294.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure496Current assets, Q2 FY2025, at 2025-06-30$495.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure483Current assets, Q3 FY2025, at 2025-09-30$482.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure475Current assets, FY2025, at 2025-12-31$474.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure463Current assets, Q1 FY2026, at 2026-03-31$463.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure907Current assets, Q2 FY2026, at 2026-06-30$907.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Total assets$m274Total assets, Q3 FY2023, at 2023-09-30$274.0m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0000950170-23-062080.Report this figure272Total assets, FY2023, at 2023-12-31$271.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0000950170-25-038758.Report this figure343Total assets, Q1 FY2024, at 2024-03-31$342.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0000950170-24-059573.Report this figure327Total assets, Q2 FY2024, at 2024-06-30$327.0m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure305Total assets, Q3 FY2024, at 2024-09-30$305.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure326Total assets, FY2024, at 2024-12-31$325.8m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure303Total assets, Q1 FY2025, at 2025-03-31$302.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure504Total assets, Q2 FY2025, at 2025-06-30$503.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure491Total assets, Q3 FY2025, at 2025-09-30$490.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure476Total assets, FY2025, at 2025-12-31$476.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure465Total assets, Q1 FY2026, at 2026-03-31$464.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure910Total assets, Q2 FY2026, at 2026-06-30$910.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Current liabilities$m12.1Current liabilities, Q3 FY2023, at 2023-09-30$12.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0000950170-23-062080.Report this figure25.9Current liabilities, FY2023, at 2023-12-31$25.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0000950170-25-038758.Report this figure25.0Current liabilities, Q1 FY2024, at 2024-03-31$25.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0000950170-24-059573.Report this figure22.1Current liabilities, Q2 FY2024, at 2024-06-30$22.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure17.0Current liabilities, Q3 FY2024, at 2024-09-30$17.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure15.9Current liabilities, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure14.0Current liabilities, Q1 FY2025, at 2025-03-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure15.2Current liabilities, Q2 FY2025, at 2025-06-30$15.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure14.7Current liabilities, Q3 FY2025, at 2025-09-30$14.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure16.6Current liabilities, FY2025, at 2025-12-31$16.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure11.5Current liabilities, Q1 FY2026, at 2026-03-31$11.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure14.2Current liabilities, Q2 FY2026, at 2026-06-30$14.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Total liabilities$m12.3Total liabilities, Q3 FY2023, at 2023-09-30$12.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0000950170-23-062080.Report this figure26.0Total liabilities, FY2023, at 2023-12-31$26.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0000950170-25-038758.Report this figure25.1Total liabilities, Q1 FY2024, at 2024-03-31$25.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0000950170-24-059573.Report this figure22.1Total liabilities, Q2 FY2024, at 2024-06-30$22.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure17.0Total liabilities, Q3 FY2024, at 2024-09-30$17.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure15.9Total liabilities, FY2024, at 2024-12-31$15.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure14.3Total liabilities, Q1 FY2025, at 2025-03-31$14.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure15.4Total liabilities, Q2 FY2025, at 2025-06-30$15.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure14.8Total liabilities, Q3 FY2025, at 2025-09-30$14.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure16.6Total liabilities, FY2025, at 2025-12-31$16.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure11.5Total liabilities, Q1 FY2026, at 2026-03-31$11.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure15.1Total liabilities, Q2 FY2026, at 2026-06-30$15.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure
Shareholders' equity$m262Shareholders' equity, Q3 FY2023, at 2023-09-30$261.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure246Shareholders' equity, FY2023, at 2023-12-31$245.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-03, accession 0001193125-26-088232.Report this figure318Shareholders' equity, Q1 FY2024, at 2024-03-31$317.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure305Shareholders' equity, Q2 FY2024, at 2024-06-30$304.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure288Shareholders' equity, Q3 FY2024, at 2024-09-30$288.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure310Shareholders' equity, FY2024, at 2024-12-31$309.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure288Shareholders' equity, Q1 FY2025, at 2025-03-31$288.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure488Shareholders' equity, Q2 FY2025, at 2025-06-30$488.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure476Shareholders' equity, Q3 FY2025, at 2025-09-30$476.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure460Shareholders' equity, FY2025, at 2025-12-31$459.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure453Shareholders' equity, Q1 FY2026, at 2026-03-31$453.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure895Shareholders' equity, Q2 FY2026, at 2026-06-30$895.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure

Cash flow

Operating cash flow−$18.5m, Q2 FY2026
Capital expenditure$99.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(15.9)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$15.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0000950170-24-126332. Derived: 9-month figure less the 6-month figure.Report this figure(12.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$12.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figure(23.4)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$23.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure(20.4)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$20.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001193125-25-179845. Derived: 6-month figure less the 3-month figure.Report this figure(12.2)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277619. Derived: 9-month figure less the 6-month figure.Report this figure(17.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$17.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(24.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$24.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(17.1)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$17.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335155. Derived: 6-month figure less the 3-month figure.Report this figure(13.3)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$13.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001193125-25-277619. Derived: 9-month figure less the 6-month figure.Report this figure(15.8)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure(19.3)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure(18.5)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$18.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001193125-26-335155. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$16.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2024-11-13, accession 0000950170-24-126332. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$14.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2025-03-13, accession 0000950170-25-038758. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$20.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-08-13, accession 0001193125-25-179845. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$22.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001193125-25-277619. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$20.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$139.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001193125-26-335155. Derived: 6-month figure less the 3-month figure.Report this figure(0.0)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2025-11-12, accession 0001193125-25-277619. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-K filed 2026-03-03, accession 0001193125-26-088232. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure0.1Capital expenditure, Q2 FY2026, three months to 2026-06-30$99.0k. XBRL concept us-gaap:PaymentsToAcquireProductiveAssets. 10-Q filed 2026-08-05, accession 0001193125-26-335155. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)66.17m, Q2 FY2026
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares3.2Diluted shares (weighted), Q3 FY2022, three months to 2022-09-303,228,692 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0000950170-23-062080.Report this figure41.0Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3140,961,024 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure41.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3040,961,024 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-13, accession 0000950170-24-096239.Report this figure41.0Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3041,030,874 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-13, accession 0000950170-24-126332.Report this figure42.0Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3142,045,608 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0000950170-25-071412.Report this figure48.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3048,075,035 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001193125-25-179845.Report this figure48.3Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3048,267,458 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure50.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3150,051,283 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure52.1Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3052,105,052 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure62.1Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3062,093,795 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001193125-25-277619.Report this figure62.8Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3162,799,326 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001193125-26-211982.Report this figure66.2Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3066,171,581 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure

Shares outstanding: 73.27mShares outstanding, period not labelled, at 2026-07-2873,270,761 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001193125-26-335155.Report this figure at Jul 28, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.